Literature DB >> 23650908

Drug-induced hperpigemntation: a systematic review.

Walter Krause1.   

Abstract

BACKGROUND: Acquired hyperpigmentation of the skin is sometimes interpreted as an adverse effect of drugs. Systematic studies are rare in the literature; predominantly case reports have been published. The present review provides evaluates the evidence for a causal relation.
METHODS: The reports on a relationship between hyperpigmentation and drugs from 1970 until June 2012 found in MEDLINE and EMBASE were rated according to the SIGN grading system for clinical studies. In this system, the grade of evidence of each report is rated. The highest grade of evidence for each drug is cited.
RESULTS: 306 publications were included. They were predominantly case reports; only a small number of case series was available. Only very few case-control-studies and randomized controlled trials (RCT) were found. For the majority of drugs, there was a low level of evidence for a causal relationship in drug-induced hyperpigmentation. A causal relationship is likely only for prostaglandins, minocycline, phenothiazine, nicotine, and antimalarial drugs.
CONCLUSIONS: There is little evidence for drug-induced hyperpigmentation. A causal relationship appears liklely only for a limited number of drugs.
© The Author • Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Year:  2013        PMID: 23650908     DOI: 10.1111/ddg.12042

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  9 in total

1.  [Diffuse grey-black hyperpigmentation of facial skin in a 59-year-old woman].

Authors:  P Nenoff; H Müller; I Schulze; A Laumanns; W Handrick
Journal:  Hautarzt       Date:  2015-03       Impact factor: 0.751

Review 2.  Pigmentation Disorders in the Elderly.

Authors:  Andrew M Armenta; Emily D Henkel; Ammar M Ahmed
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

3.  Minocycline-induced Hyperpigmentation.

Authors:  Timothy Judson; Kip Mihara
Journal:  J Gen Intern Med       Date:  2016-05-12       Impact factor: 5.128

4.  Minocycline-induced hyperpigmentation.

Authors:  Valena Fiscus; Andrew Hankinson; Richard Alweis
Journal:  J Community Hosp Intern Med Perspect       Date:  2014-07-31

5.  Tigecycline Induced Hyperpigmentation of the Skin.

Authors:  S J Vandecasteele; J De Ceulaer; E Wittouck
Journal:  Open Forum Infect Dis       Date:  2016-02-17       Impact factor: 3.835

Review 6.  Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review.

Authors:  Guanhao Zheng; Li Cao; Zaiqian Che; Enqiang Mao; Erzhen Chen; Juan He
Journal:  BMC Pharmacol Toxicol       Date:  2018-07-04       Impact factor: 2.483

7.  Severe Type of Minocycline-Induced Hyperpigmentation Mimicking Peripheral Arterial Occlusive Disease in a Bullous Pemphigoid Patient.

Authors:  Meng-Yu Wu; Yueh-Tseng Hou; Giou-Teng Yiang; Andy Po-Yi Tsai; Ching-Hsiang Lin
Journal:  Antibiotics (Basel)       Date:  2019-07-16

8.  Levetiracetam-Induced Skin Hyperpigmentation: An Extremely Rare Undesirable Side Effect.

Authors:  Hussein Algahtani; Siham Marghalani; Mohamed Satti; Bader Shirah
Journal:  J Epilepsy Res       Date:  2017-12-31

Review 9.  A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea.

Authors:  Ana M Martins; Joana M Marto; Jodi L Johnson; Emmy M Graber
Journal:  Antibiotics (Basel)       Date:  2021-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.